Literature DB >> 11289802

Immunomodulatory proteins of myxoma virus.

J W Barrett1, J X Cao, S Hota-Mitchell, G McFadden.   

Abstract

Poxviruses collectively encode an impressive collection of diverse immunomodulatory proteins. In this review we draw attention to some of the new open reading frames (ORFs) discovered during the sequencing of the myxoma virus DNA genome [Cameron C, Hota-Mitchell S, Chen L, Barrett J, Cao J-X, Macaulay C, Willer D, Evans D, McFadden G (1999) The complete DNA sequence of myxoma virus. Virology 264:298-318] that may function to subvert the host immune system. Most of these predicted functions are speculative but some of the deduced primary amino acid sequences contain intriguing similarities to known cellular and viral proteins in the public domain for which immunomodulatory functions have been assigned. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289802     DOI: 10.1006/smim.2000.0298

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  29 in total

1.  Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways.

Authors:  Masmudur M Rahman; Grant McFadden
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Oncolytic Poxviruses.

Authors:  Winnie M Chan; Grant McFadden
Journal:  Annu Rev Virol       Date:  2014-09-01       Impact factor: 10.431

3.  M135R is a novel cell surface virulence factor of myxoma virus.

Authors:  John W Barrett; Joanna Sypula; Fuan Wang; Lindsay R Alston; Zhuhong Shao; Xiujuan Gao; Timothy S Irvine; Grant McFadden
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

Review 4.  Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.

Authors:  Masmudur M Rahman; Gerard J Madlambayan; Christopher R Cogle; Grant McFadden
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-07       Impact factor: 7.638

5.  Myxoma and vaccinia viruses bind differentially to human leukocytes.

Authors:  Winnie M Chan; Eric C Bartee; Jan S Moreb; Ken Dower; John H Connor; Grant McFadden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

6.  Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus.

Authors:  Raymond S Weinstein; Michael M Weinstein; Kenneth Alibek; Michael I Bukrinsky; Beda Brichacek
Journal:  BMC Immunol       Date:  2010-05-18       Impact factor: 3.615

7.  Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.

Authors:  Mónica Morales; Miguel A Ramírez; María J Cano; Mario Párraga; Joaquín Castilla; Luis I Pérez-Ordoyo; Juan M Torres; Juan Bárcena
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

8.  Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200).

Authors:  Leiliang Zhang; Marianne Stanford; Jia Liu; Catherine Barrett; Lei Jiang; A Neil Barclay; Grant McFadden
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

9.  Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses.

Authors:  Mohamed R Mohamed; Masmudur M Rahman; Jerry S Lanchbury; Donna Shattuck; Chris Neff; Max Dufford; Nick van Buuren; Katharine Fagan; Michele Barry; Scott Smith; Inger Damon; Grant McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

10.  Co-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013.

Authors:  Masmudur M Rahman; Mohamed R Mohamed; Manbok Kim; Sherin Smallwood; Grant McFadden
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.